Conjunctivitis
📧 Sign up to get email alerts when something new happens for Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora [Phase 4]
A Phase 4 clinical trial from the University of Sao Paulo evaluates different regimens of povidone-iodine 5% eye drops for reducing conjunct…
-
CLINICAL_TRIALS withdrawal · 2016-06-23Clinical Trial Update: Efficacy and Safety of Grass-SPIRE Registration Study [Phase 2, Phase 3]
Circassia Limited has withdrawn the Grass-SPIRE registration study, a Phase 2/3 trial, for rhinitis and conjunctivitis.
-
FDA approval · 2016-03-10FDA Approved: MAXIDEX — Supplemental Application (Harrow Eye, LLC)
FDA approved a supplemental application for MAXIDEX (dexamethasone) from Harrow Eye, LLC.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Moxifloxacin vs. Polytrim for Conjunctivitis [Phase 4]
Phase 4 trial comparing moxifloxacin ophthalmic solution with Polytrim for conjunctivitis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis [Phase 3]
Phase III trial evaluating 0.1% tacrolimus ophthalmic suspension for Vernal keratoconjunctivitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Influence of Cosmetic Color Tinted Contact Lenses on the Ocular Surface
Completed clinical trial assessing the impact of cosmetic color-tinted contact lenses on the ocular surface, focusing on conjunctival inflam…
-
FDA approval · 2013-12-16FDA Approved: LOTEPREDNOL ETABONATE — Supplemental Application (Bausch & Lomb Americas Inc.)
The FDA approved a supplemental application for Loteprednol Etabonate (Lotemax) from Bausch & Lomb Americas Inc.
-
FDA approval · 2013-02-12FDA Approved: FML — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for FML (fluorometholone), resulting in updated labeling for the ophthalmic corticosteroid.
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis [NA]
Clinical trial comparing the RPS Adeno Detector IV to viral cell culture for detecting adenoviral conjunctivitis; study completed with resul…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus [Phase 3]
This entry describes a Phase 3 clinical trial evaluating ganciclovir gel 0.3% for adenoviral conjunctivitis.
-
CLINICAL_TRIALS trial_result · 2011-09-15Clinical Trial Update: Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis [Phase 3]
Phase 3 trial comparing Loteprednol etabonate with Tobramycin versus Tobramycin with Dexamethasone for blepharokeratoconjunctivitis has comp…
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis [Phase 4]
A Phase 4 clinical trial comparing Zylet (tobramycin + loteprednol etabonate) to Lotemax, tobramycin, and vehicle in pediatric blepharoconju…
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis [Phase 3]
Phase 3 trial assessing safety and efficacy of an antibiotic-steroid eye drop combination for blepharitis, keratitis, and conjunctivitis; tr…
-
FDA approval · 2010-06-03FDA Approved: LOTEPREDNOL ETABONATE AND TOBRAMYCIN — Supplemental Application (Bausch & Lomb Americas Inc.)
FDA approved a supplemental application for Loteprednol etabonate and tobramycin, expanding labeling to treat inflammatory ocular conditions…
-
CLINICAL_TRIALS trial_result · 2010-02-11Clinical Trial Update: Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears [NA]
This clinical trial evaluated a rapid screening test for detecting adenovirus in tears, in the context of acute conjunctivitis and adenovira…
-
CLINICAL_TRIALS research · 2009-07-22Clinical Trial Update: Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations
Completed clinical trial report describes how glaucoma patients use eye drops, assessed via patient surveys and video observations to evalua…
-
FDA approval · 2009-03-20FDA Approved: DIFLUPREDNATE OPHTHALMIC — Supplemental Application (Sandoz Inc)
FDA approved Sandoz Inc's supplemental application for difluprednate ophthalmic, approving a generic corticosteroid ophthalmic solution for …
-
CLINICAL_TRIALS trial_result · 2008-04-04Clinical Trial Update: Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis [Phase 3]
Phase III long-term, open-label extension study of 0.1% tacrolimus ophthalmic suspension in vernal keratoconjunctivitis completed.